[{"id":"6d47cf58-c1e8-40cb-9336-c3af2e42c71f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05215015","created_at":"2022-02-05T18:27:41.589Z","updated_at":"2024-07-02T16:36:17.805Z","phase":"Phase 1","brief_title":"Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia","source_id_and_acronym":"NCT05215015","lead_sponsor":"Wuxi People's Hospital","biomarkers":" IL6 • TNFA • CD33 • IL2 • IL10","pipe":" | ","alterations":" CD33 positive","tags":["IL6 • TNFA • CD33 • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD33 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IBR733"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 11/30/2020","start_date":" 11/30/2020","primary_txt":" Primary completion: 11/30/2022","primary_completion_date":" 11/30/2022","study_txt":" Completion: 11/30/2022","study_completion_date":" 11/30/2022","last_update_posted":"2022-01-31"}]